Oculotoxicities of Systemically Administered Drugs
- 1 January 1986
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 2 (4) , 385-404
- https://doi.org/10.1089/jop.1986.2.385
Abstract
There have been many drugs reported to cause oculotoxic responses after their systemic administration. The severity of these toxicities range from minor ocular inconvenience to permanent loss of vision. This paper reviews the current literature and attempts to suggest some probable factors involved in the development of oculotoxicities by systemic drugs. Various drug entry and exit pathways in the eye are presented and the role of some intraocular structures in the toxicity development is examined. The issues of melanin binding, genetic heterogeneity, photosensitivity and environmental pollution are discussed.Keywords
This publication has 44 references indexed in Scilit:
- The aetiology of SMON may involve an interaction between clioquinol and environmental metalsMedical Hypotheses, 1984
- NEBULISED IPRATROPIUM BROMIDE AND SALBUTAMOL CAUSING CLOSED-ANGLE GLAUCOMAThe Lancet, 1984
- Central serous chorioretinopathy complicating systemic corticosteroid treatment.British Journal of Ophthalmology, 1984
- TRIFLUOPERAZINE: CORNEAL ENDOTHELIAL PHOTOTOXICITYPhotochemistry and Photobiology, 1983
- Amitriptyline: Another cause of internuclear ophthalmoplegia with comaAnnals of Neurology, 1982
- Genetic differences in drug metabolism associated with ocular toxicity.Environmental Health Perspectives, 1982
- Antimalarials and ophthalmologic safetyJournal of the American Academy of Dermatology, 1982
- Clioquinol Intoxication Occurring in the Treatment of Acrodermatitis Enteropathica with Reference to SMON Outside of JapanClinical Toxicology, 1981
- Interaction of drugs with ocular melanin in vitroExperimental Eye Research, 1980